Pharmaceutical Desiccant Market

Pharmaceutical Desiccants Market Research Report Information By Type (Silica Gel, Activated, Carbonclay Desiccant, Molecular Sieves), By End-use (Tablets, API’s, Capsules, Nutraceutical Product Packaging), and By Region - Global Forecast to 2035
ID: MRFR/CnM/2838-CR
111 Pages
Chitranshi Jaiswal
Last Updated: May 15, 2026
Pharmaceutical Desiccant Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.77%
2024 Market Size$ 105.6 Million
2025 Market Size$ 110.64 Million
2035 Market Size$ 176.34 Million
Key Players
Desiccare Inc
Sorbent Systems
Clariant AG
W.R. Grace & Co
Mitsubishi Chemical Corporation
BASF SE
Opportunities
  • Stringent Regulatory Standards
  • Growth of E-commerce in Pharmaceuticals
  • Increased Focus on Sustainable Practices

Pharmaceutical Desiccant Market Summary

As per Market Research Future analysis, the Pharmaceutical Desiccants Market Size was estimated at 105.6 USD Million in 2024. The Pharmaceutical Desiccants industry is projected to grow from 110.64 USD Million in 2025 to 176.34 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.77% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Pharmaceutical Desiccants Market is poised for growth driven by sustainability and technological advancements.

  • Sustainable desiccant solutions are gaining traction as the industry shifts towards eco-friendly practices.
  • Technological advancements in desiccants are enhancing performance and efficiency, particularly in North America.
  • Regulatory compliance and quality assurance remain critical, especially in the largest segment of silica gel.
  • The rising demand for pharmaceutical products and stringent regulatory standards are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 105.6 (USD Million)
2035 Market Size 176.34 (USD Million)
CAGR (2025 - 2035) 4.77%

Major Players

Desiccare Inc (US), Sorbent Systems (US), Clariant AG (CH), W.R. Grace & Co (US), Mitsubishi Chemical Corporation (JP), BASF SE (DE), Sealed Air Corporation (US), Huntsman Corporation (US), Molecular Products (GB)

Pharmaceutical Desiccant Market Drivers

Stringent Regulatory Standards

Stringent regulatory standards imposed by health authorities are a crucial driver for the Pharmaceutical Desiccants Market. Regulatory bodies require pharmaceutical manufacturers to adhere to strict guidelines regarding product stability and quality. This necessitates the use of effective desiccants to prevent moisture-related degradation. Compliance with these regulations not only ensures product safety but also enhances consumer trust. As the industry continues to evolve, the emphasis on quality assurance is likely to increase, further driving the demand for reliable desiccants in the Pharmaceutical Desiccants Market.

Growth of E-commerce in Pharmaceuticals

The growth of e-commerce in the pharmaceutical sector is reshaping the Pharmaceutical Desiccants Market. With the rise of online pharmacies and direct-to-consumer sales, the need for effective packaging solutions that include desiccants is becoming more pronounced. E-commerce platforms require products to maintain their integrity during transit, which is where desiccants play a vital role. As online sales of pharmaceuticals are projected to increase, the demand for desiccants that ensure product stability during shipping is likely to grow, thereby benefiting the Pharmaceutical Desiccants Market.

Increased Focus on Sustainable Practices

An increased focus on sustainable practices within the pharmaceutical industry is emerging as a significant driver for the Pharmaceutical Desiccants Market. Companies are increasingly seeking eco-friendly desiccant solutions that minimize environmental impact while maintaining product efficacy. The shift towards sustainability is prompting manufacturers to explore biodegradable and reusable desiccants. This trend not only aligns with global sustainability goals but also appeals to environmentally conscious consumers. As the industry adapts to these changing preferences, the demand for sustainable desiccants is expected to rise, positively impacting the Pharmaceutical Desiccants Market.

Rising Demand for Pharmaceutical Products

The increasing demand for pharmaceutical products is a primary driver of the Pharmaceutical Desiccants Market. As the global population ages and the prevalence of chronic diseases rises, the need for effective drug formulations intensifies. This surge in demand necessitates the use of desiccants to maintain the stability and efficacy of pharmaceutical products. According to industry reports, the pharmaceutical sector is projected to grow at a compound annual growth rate of approximately 5.8% over the next few years. Consequently, the Pharmaceutical Desiccants Market is likely to experience parallel growth, as manufacturers seek to enhance product shelf life and ensure quality through moisture control.

Technological Innovations in Desiccant Materials

Technological advancements in desiccant materials are significantly influencing the Pharmaceutical Desiccants Market. Innovations such as the development of more efficient silica gel and molecular sieves are enhancing moisture absorption capabilities. These advancements not only improve the performance of desiccants but also reduce costs associated with product degradation. The introduction of smart desiccants, which can indicate moisture levels, is also gaining traction. As pharmaceutical companies increasingly adopt these advanced materials, the demand for high-performance desiccants is expected to rise, thereby propelling the Pharmaceutical Desiccants Market forward.

Market Segment Insights

By Type: Silica Gel (Largest) vs. Molecular Sieves (Fastest-Growing)

The Pharmaceutical Desiccants Market is largely dominated by Silica Gel, which accounts for the majority of market share due to its widespread use and reliability in moisture control within pharmaceutical packaging. Activated Carbon and Clay Desiccant follow in terms of market presence, although they hold smaller shares compared to Silica Gel. Molecular Sieves, while less prevalent historically, are gaining traction as manufacturers seek more efficient desiccants, diversifying the market further and promising shifts in traditional usage patterns.

Silica Gel (Dominant) vs. Molecular Sieves (Emerging)

Silica Gel is the dominant player in this segment due to its effective moisture absorption capabilities and versatility across various pharmaceutical applications. Its established presence ensures a consistent demand as pharmaceutical companies prioritize reliability in moisture control. On the other hand, Molecular Sieves are emerging as a key competitor owing to their superior adsorption properties, particularly for selective moisture removal in more specialized applications. As the demand for advanced pharmaceutical solutions rises, Molecular Sieves are expected to gain a larger market share, driven by innovative formulations and targeted regulatory requirements that demand higher efficiency in desiccant performance.

By End-use: Tablets (Largest) vs. Nutraceutical Product Packaging (Fastest-Growing)

In the Pharmaceutical Desiccants Market, the end-use segments show a varied distribution with tablets holding the largest share due to their widespread application in pharmaceuticals. API's and capsules also contribute significantly to the market but at a slower rate compared to the tablet segment. Nutraceutical product packaging, albeit smaller in share, is rapidly gaining ground as more consumers gravitate towards health supplements and nutraceuticals, highlighting changing preferences in end-use applications.

Tablets (Dominant) vs. Nutraceutical Product Packaging (Emerging)

Tablets remain the dominant segment within the Pharmaceutical Desiccants Market, largely due to their established usage in drug formulation and distribution. The presence of active pharmaceutical ingredients (APIs) also enhances the stability of tablets, making them preferred by manufacturers. On the other hand, nutraceutical product packaging is an emerging segment driven by the rising consumer awareness of health and wellness products. This shift towards nutraceuticals is supported by the increasing demand for effective moisture control solutions in packaging to maintain product integrity and freshness, marking a significant trend in the market.

Get more detailed insights about Pharmaceutical Desiccant Market

Regional Insights

North America : Pharmaceutical Innovation Leader

North America is the largest market for pharmaceutical desiccants, holding approximately 40% of the global share. The region's growth is driven by increasing demand for moisture-sensitive pharmaceuticals and stringent regulatory requirements for product stability. The presence of major pharmaceutical companies and advanced manufacturing technologies further catalyze market expansion. Regulatory bodies like the FDA enforce strict guidelines, ensuring high-quality standards in pharmaceutical packaging. The United States is the leading country in this market, followed by Canada. Key players such as Desiccare Inc, Sorbent Systems, and W.R. Grace & Co dominate the landscape, leveraging innovative technologies to enhance product performance. The competitive environment is characterized by continuous research and development efforts, aimed at improving desiccant efficiency and sustainability. This dynamic market is expected to witness further growth as the pharmaceutical sector expands.

Europe : Regulatory-Driven Market Growth

Europe is the second-largest market for pharmaceutical desiccants, accounting for approximately 30% of the global share. The region's growth is fueled by increasing regulatory requirements for drug stability and the rising prevalence of chronic diseases. The European Medicines Agency (EMA) plays a crucial role in establishing guidelines that promote the use of effective desiccants in pharmaceutical packaging, ensuring product integrity and safety. Germany, France, and the UK are the leading countries in this market, with a strong presence of key players like BASF SE and Clariant AG. The competitive landscape is marked by innovation and collaboration among companies to develop advanced desiccant solutions. The focus on sustainability and eco-friendly materials is also gaining traction, as manufacturers aim to meet both regulatory standards and consumer expectations for environmentally responsible products. The market is poised for growth as the pharmaceutical industry continues to evolve.

Asia-Pacific : Emerging Market Potential

Asia-Pacific is witnessing significant growth in the pharmaceutical desiccants market, holding approximately 25% of the global share. The region's expansion is driven by increasing pharmaceutical production, rising healthcare expenditures, and growing awareness of product stability. Countries like China and India are at the forefront, supported by favorable government initiatives and investments in the healthcare sector, which are enhancing the demand for effective desiccant solutions. China is the largest market in the region, followed by India and Japan. The competitive landscape features both local and international players, including Mitsubishi Chemical Corporation and Sealed Air Corporation. The market is characterized by rapid technological advancements and a focus on developing innovative desiccant materials. As the pharmaceutical industry continues to grow, the demand for reliable desiccants is expected to rise, further propelling market growth in this dynamic region.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa represent an emerging market for pharmaceutical desiccants, accounting for approximately 5% of the global share. The growth in this region is driven by increasing investments in healthcare infrastructure and a rising demand for pharmaceuticals. Regulatory bodies are beginning to establish guidelines that promote the use of desiccants, which is expected to enhance product quality and safety in pharmaceutical packaging. Countries like South Africa and the UAE are leading the market, with a growing number of pharmaceutical manufacturers seeking effective desiccant solutions. The competitive landscape is still developing, with opportunities for both local and international players to enter the market. As awareness of product stability and quality increases, the demand for pharmaceutical desiccants is anticipated to grow, making this region a key area for future investment and development.

Pharmaceutical Desiccant Market Regional Image

Key Players and Competitive Insights

The Pharmaceutical Desiccants Market is currently characterized by a dynamic competitive landscape, driven by increasing demand for moisture control solutions in the pharmaceutical sector. Key players such as Desiccare Inc (US), Clariant AG (CH), and BASF SE (DE) are strategically positioning themselves through innovation and regional expansion. Desiccare Inc (US) focuses on developing advanced desiccant solutions tailored for specific pharmaceuticalapplications, while Clariant AG (CH) emphasizes sustainability in its product offerings, aligning with global trends towards eco-friendly practices. BASF SE (DE) is leveraging its extensive research capabilities to enhance product performance, thereby shaping a competitive environment that prioritizes quality and innovation.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market appears moderately fragmented, with several players vying for market share, yet the collective influence of major companies like W.R. Grace & Co (US) and Mitsubishi Chemical Corporation (JP) is notable. These firms are not only enhancing their operational efficiencies but also collaborating with local distributors to strengthen their market presence.
In August W.R. Grace & Co (US) announced a strategic partnership with a leading pharmaceutical manufacturer to co-develop a new line of desiccants specifically designed for biologics. This collaboration is significant as it underscores the growing need for specialized moisture control solutions in the rapidly evolving biopharmaceutical sector, potentially positioning W.R. Grace as a leader in this niche market.
In September Mitsubishi Chemical Corporation (JP) launched a new range of biodegradable desiccants aimed at reducing environmental impact. This initiative reflects a broader industry trend towards sustainability, suggesting that Mitsubishi is not only responding to regulatory pressures but also appealing to environmentally conscious consumers, thereby enhancing its competitive edge.
In October Clariant AG (CH) unveiled a digital platform that integrates AI to optimize desiccant performance monitoring for pharmaceutical clients. This move indicates a shift towards digitalization in the industry, allowing Clariant to offer enhanced value through data-driven insights, which could lead to improved customer satisfaction and loyalty.
As of October the competitive trends in the Pharmaceutical Desiccants Market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing product offerings and market reach. Looking ahead, it is likely that competitive differentiation will evolve from traditional price-based strategies to a focus on innovation, technological advancements, and supply chain reliability, reflecting the changing demands of the pharmaceutical industry.

Key Companies in the Pharmaceutical Desiccant Market include

Industry Developments

October 2018: Sanner expanded its product portfolio for pharmaceutical and healthcare applications in India, introducing test strip packaging solutions. The solution provides high density and optimum moisture regulation, which is expected to boost the demand for pharmaceutical desiccants in the Asia-Pacific market.

September 2018, CSP Technologies, Inc. collaborated with PCI Pharma Services to actively carry out clinical trials and stability tests for Activ-Blister packaging solutions. These solutions act as desiccants, which protect pharmaceutical and medical products from odor, moisture, and oxygen while increasing the product's shelf-life. 

September 2018: Multisorb Technologies was acquired by Filtration Group. It has set up a new manufacturing unit in Hyderabad, India, which has the capacity to develop over 30 crore pieces of products such as Multisorb's StripPax, MiniPax, StabilOx, and IntelliSorb active packaging components. These products are expected to offer physical and chemical solutions to the pharmaceutical and medical devices industries across India and other Asian countries.

Future Outlook

Pharmaceutical Desiccant Market Future Outlook

The Pharmaceutical Desiccants Market is projected to grow at a 4.77% CAGR from 2025 to 2035, driven by increasing demand for moisture-sensitive products and advancements in packaging technologies.

New opportunities lie in:

  • Development of biodegradable desiccants for eco-friendly packaging solutions. Integration of smart desiccant systems with IoT for real-time monitoring. Expansion into emerging markets with tailored desiccant solutions for local pharmaceutical needs.

By 2035, the market is expected to solidify its position as a critical component in pharmaceutical packaging.

Market Segmentation

Pharmaceutical Desiccant Market Type Outlook

  • Silica Gel
  • Activated Carbon
  • Clay Desiccant
  • Molecular Sieves

Pharmaceutical Desiccant Market End-use Outlook

  • Tablets
  • API’s
  • Capsules
  • Nutraceutical Product Packaging

Report Scope

MARKET SIZE 2024 105.6(USD Million)
MARKET SIZE 2025 110.64(USD Million)
MARKET SIZE 2035 176.34(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.77% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Desiccare Inc (US), Sorbent Systems (US), Clariant AG (CH), W.R. Grace & Co (US), Mitsubishi Chemical Corporation (JP), BASF SE (DE), Sealed Air Corporation (US), Huntsman Corporation (US), Molecular Products (GB)
Segments Covered Type, End-use, Region - Global Forecast to 2035
Key Market Opportunities Growing demand for moisture-sensitive pharmaceuticals drives innovation in Pharmaceutical Desiccants Market solutions.
Key Market Dynamics Rising demand for moisture control in pharmaceuticals drives innovation and competition among desiccant manufacturers.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Pharmaceutical Desiccants Market?

As of 2024, the Pharmaceutical Desiccants Market was valued at 105.6 USD Million.

What is the projected market valuation for the Pharmaceutical Desiccants Market in 2035?

The market is projected to reach a valuation of 176.34 USD Million by 2035.

What is the expected CAGR for the Pharmaceutical Desiccants Market during the forecast period 2025 - 2035?

The expected CAGR for the Pharmaceutical Desiccants Market during the forecast period 2025 - 2035 is 4.77%.

Which types of desiccants are leading in the market based on valuation?

Silica Gel, with a valuation range of 30.0 to 50.0 USD Million, appears to be a leading type in the market.

What are the key end-use segments for Pharmaceutical Desiccants?

Key end-use segments include Tablets, API’s, Capsules, and Nutraceutical Product Packaging, with Tablets valued between 30.0 and 50.0 USD Million.

Who are the major players in the Pharmaceutical Desiccants Market?

Major players include Desiccare Inc, Sorbent Systems, Clariant AG, and W.R. Grace & Co, among others.

What is the valuation range for Molecular Sieves in the Pharmaceutical Desiccants Market?
Molecular Sieves are valued between 30.6 and 56.34 USD Million in the market.
How does the valuation of Activated Carbon compare to other desiccants?
Activated Carbon has a valuation range of 25.0 to 40.0 USD Million, indicating a competitive position among desiccants.
What is the significance of the growth forecast for the Pharmaceutical Desiccants Market?
The growth forecast suggests a robust expansion, with the market expected to grow from 105.6 USD Million in 2024 to 176.34 USD Million by 2035.
What trends are influencing the Pharmaceutical Desiccants Market?
Trends such as increasing demand for effective moisture control in pharmaceutical packaging are likely influencing market dynamics.
Author
Author
Author Profile
Chitranshi Jaiswal LinkedIn
Team Lead - Research
Chitranshi is a Team Leader in the Chemicals & Materials (CnM) and Energy & Power (EnP) domains, with 6+ years of experience in market research. She leads and mentors teams to deliver cross-domain projects that equip clients with actionable insights and growth strategies. She is skilled in market estimation, forecasting, competitive benchmarking, and both primary & secondary research, enabling her to turn complex data into decision-ready insights. An engineer and MBA professional, she combines technical expertise with strategic acumen to solve dynamic market challenges. Chitranshi has successfully managed projects that support market entry, investment planning, and competitive positioning, while building strong client relationships. Certified in Advanced Excel & Power BI she leverages data-driven approaches to ensure accuracy, clarity, and impactful outcomes.

Research Approach

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed scientific journals, chemical engineering publications, and authoritative industrial organizations. Key sources included the US Food & Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), European Medicines Agency (EMA) Quality Guidelines, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH Q1A Stability Testing Guidelines), United States Pharmacopeia (USP <1191> Stability Considerations in Dispensing Practice), European Pharmacopoeia (Ph. Eur. 5.11 Characters Section in Monographs), International Organization for Standardization (ISO 10993 Biocompatibility Standards), ASTM International (ASTM D1990 Standard Test Methods for Determining Water Vapor Sorption), World Health Organization (WHO) Prequalification Programme for Medicines, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Japan Ministry of Health, Labour and Welfare (MHLW) Pharmaceutical and Food Safety Bureau, China National Medical Products Administration (NMPA) Drug Review Center, India Central Drugs Standard Control Organization (CDSCO), International Federation of Pharmaceutical Manufacturers Associations (IFPMA), European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceutical Research and Manufacturers of America (PhRMA), International Desiccant Association (IDA), American Chemical Society (ACS) Publications, Royal Society of Chemistry (RSC) Journals, ScienceDirect/Elsevier Chemical Engineering Journals, Wiley Online Library Packaging Technology & Science, Smithers Pira Packaging Market Reports, Freedonia Group Chemical Packaging Studies, and national pharmaceutical production statistics from key markets (China National Bureau of Statistics, India Department of Pharmaceuticals, US Census Bureau Manufacturing Data). These sources were used to collect desiccant consumption data, regulatory compliance requirements, stability testing protocols, pharmaceutical packaging standards, raw material price indices, and market landscape analysis for silica gel, activated carbon, clay desiccant, and molecular sieve technologies.

Primary Research

During the primary research process, qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders. Supply-side sources included CEOs, VPs of Manufacturing Operations, regulatory affairs heads, R&D directors, and commercial directors from pharmaceutical desiccant manufacturers, chemical specialty companies, and packaging solution OEMs. Demand-side sources included pharmaceutical quality assurance directors, packaging engineers, formulation scientists, supply chain managers, and procurement leads from multinational pharmaceutical companies, generic drug manufacturers, contract manufacturing organizations (CMOs), nutraceutical producers, and medical device firms. The primary research validated market segmentation, confirmed product pipeline timelines, and gathered insights on regulatory compliance patterns, pricing strategies, sustainability initiatives, and substitution dynamics between desiccant types. CEOs, VPs of Manufacturing Operations, regulatory affairs leaders, R&D directors, and commercial directors from pharmaceutical desiccant manufacturers, chemical specialty companies, and packaging solution OEMs comprised the supply-side sources. Multinational pharmaceutical companies, generic drug manufacturers, contract manufacturing organizations (CMOs), nutraceutical producers, and medical device firms comprised demand-side sources, including pharmaceutical quality assurance directors, packaging engineers, formulation scientists, supply chain managers, and procurement leads. Market segmentation was validated, product pipeline timelines were confirmed, and insights regarding regulatory compliance patterns, pricing strategies, sustainability initiatives, and substitution dynamics between desiccant types were obtained through primary research.

Primary Respondent Breakdown:

By Designation: C-level Primaries (30%), Director Level (32%), Others (38%)

By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

Market Size Estimation

Global market valuation was derived through revenue mapping and consumption volume analysis. The methodology included:

Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America

Product mapping across silica gel, activated carbon, clay desiccant, molecular sieve, and emerging biodegradable desiccant categories

Analysis of reported and modeled annual revenues specific to pharmaceutical-grade desiccant portfolios

Coverage of manufacturers representing 72–78% of global market share in 2024

Extrapolation using bottom-up (pharmaceutical packaging volume × desiccant unit consumption × ASP by country) and top-down (manufacturer revenue validation) approaches to derive segment-specific valuations

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.